E.g., 02/27/2021
E.g., 02/27/2021

BioFire’s FilmArray® Meningitis/Encephalitis Panel gets CE marked

26 January, 2016

 FilmArray® expanded menu, with a fourth panel, is the largest available on a molecular biology multiplex platfom.

BioFire Submits Special 510(k) Application to the FDA for the use of FilmArray® Torch, the New High Throughput FilmArray® System with FilmArray® Respiratory Panel

12 January, 2016

bioMérieux, a world leader in the field of in vitro diagnostics, today announced that BioFire Diagnostics, LLC, its molecular biology affiliate, has submitted the FilmArray® Torch to the U.S. Food and Drug Administration (FDA) for special1 510(k) clearance for use with the FilmArray® Respiratory Panel (RP).

bioMérieux introduces GENE-UP®, a new molecular diagnostic solution for food pathogen detection jointly developed with BioFire

04 November, 2015

New generation PCR system benefits from the combined expertise of bioMérieux, world leader in microbiological food safety control and of BioFire, reputed for its know-how in molecular biology

BioFire Receives FDA Clearance for the FilmArray® 2.0 System

26 February, 2015

New system delivers higher throughput, single database management and minimized footprint

bioMérieux and Illumina Enter Agreement to Co-Develop a Next-Generation Sequencing Solution for Epidemiological Monitoring of Bacterial Infections

25 November, 2014

Marcy l’Etoile, France – San Diego, California, United States – November 18, 2014 – bioMérieux, a world leader in the field of in vitro diagnostics, and Illumina, a world leader in genomics, announced they have signed an exclusive agreement to launch a next-generation sequencing (NGS) epidemiology solution for service labs. The two companies will jointly develop applications for microbiology sequencing technologies within a four-year renewable period.

Pioneering diagnostics